Amneal Pharmaceuticals Q4 2025 Earnings Preview
Source: SeekingAlpha
2026-02-26 10:41:29 ET
More on Amneal Pharmaceuticals
- Amneal Pharmaceuticals, Inc. (AMRX) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Amneal Pharmaceuticals, Inc. (AMRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Amneal: Growing Drug Portfolio, Positive Cash Flow, Outweighing Leverage Risks
- Amneal initiates nationwide settlement for opioid-related claims
- TTM Technologies, Dutch Bros to join S&P 400 Index; Amneal, Apellis to be part of S&P SmallCap 600
Read the full article on Seeking Alpha
For further details see:
Amneal Pharmaceuticals Q4 2025 Earnings Preview
Amneal Pharmaceuticals Inc. Class A
NASDAQ: AMRX
AMRX Trading
-0.54% G/L:
$11.97 Last:
1,130,370 Volume:
$12.26 Open:
AMRX Latest News
AMRX Stock Data
$4,628,993,997
156,741,352
0.09%
93
N/A
Pharmaceuticals
Healthcare
US
Bridgewater
